Chemoinformaics analysis of Lavandulyl-2-Methyl-Butyrate
| Molecular Weight | 238.371 | nRot | 8 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 3 |
| Exact Molecular Weight | 238.193 | nRing | 0 |
| Solubility: LogS | -3.986 | nHRing | 0 |
| Solubility: LogP | 4.518 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 43.9906 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.469 |
| Synth | 3.62 |
| Natural Product Likeliness | 1.272 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.462 |
| MDCK | 0.0000253 |
| BBB | 0.974 |
| PPB | 0.619609 |
| VDSS | 1.73 |
| FU | 0.442293 |
| CYP1A2-inh | 0.417 |
| CYP1A2-sub | 0.408 |
| CYP2c19-inh | 0.246 |
| CYP2c19-sub | 0.9 |
| CYP2c9-inh | 0.082 |
| CYP2c9-sub | 0.478 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.824 |
| CYP3a4-inh | 0.224 |
| CYP3a4-sub | 0.337 |
| CL | 9.875 |
| T12 | 0.219 |
| hERG | 0.019 |
| Ames | 0.017 |
| ROA | 0.028 |
| SkinSen | 0.122 |
| Carcinogencity | 0.394 |
| EI | 0.761 |
| Respiratory | 0.839 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.803362 |